COVID-19 sends STEMI to quarantine!? by Abdi, S. et al.
Vol.:(0123456789) 
Clinical Research in Cardiology (2020) 109:1567–1568 
https://doi.org/10.1007/s00392-020-01664-3
LETTER TO THE EDITORS
COVID‑19 sends STEMI to quarantine!?
Seifollah Abdi1 · Mojtaba Salarifar2 · Seyedeh Hamideh Mortazavi2 · Parham Sadeghipour1 · Babak Geraiely3 
Received: 24 April 2020 / Accepted: 5 May 2020 / Published online: 20 May 2020 
© Springer-Verlag GmbH Germany, part of Springer Nature 2020
Sirs,
In December 2019, severe acute respiratory syndrome Cor-
onavirus 2 (SARS-COV-2), termed “novel COVID-19”, 
emerged in China and was considered a pandemic by the 
World Health Organization (WHO) on March 11, 2020 [1]. 
So far, a sizable population of the world has been affected 
[2] and many have expired. Although an epidemic neces-
sitates the organization of medical and health facilities to 
control the crisis, the provision of services to other patients, 
who may have serious conditions, should not be neglected 
because of the catastrophic consequences.
In Iran, 24/7 primary percutaneous coronary interven-
tion (PCI) as the standard treatment strategy for patients 
with ST-elevation myocardial infarction (STEMI) [3–7] was 
launched in September 2015 to achieve a fair distribution of 
healthcare resources. Currently, 49 general and heart hos-
pitals provide these services, with 48 915 patients having 
undergone primary PCI thus far.
With the outbreak of the Coronavirus, the first case of 
COVID-19 was officially reported on February 19, 2020. 
As is shown in Fig. 1, we have found a significant drop 
(approximately 25–40%) in the number of documented 
STEMI patients who have undergone primary PCI in our 
24/7 primary PCI-capable hospitals.
What may be responsible for this decline is patients’ fear 
of contamination with the Coronavirus in hospitals or the 
exhaustion of the entire health system resources by COVID-
19 patients. On the other hand, the manifestation of critical 
STEMI with dyspnea and pulmonary edema could be mis-
taken with the Coronavirus features, resulting in the man-
agement of the patient as a COVID-19 case from the outset. 
In the worst-case scenario, the patient might expire at home 
due to a wasted time interval between the symptom onset 
and the first medical contact.
According to recent reports [8–10], the number of 
patients undergoing primary PCI and acute coronary syn-
drome admissions have also dropped significantly in other 
countries. Indubitably, this is an extremely worrying issue 
with adverse long-term consequences for patients and 
healthcare systems.
We suggest that the general population be fully informed 
as regards the symptoms of STEMI by social media. We also 
herewith underscore the vital importance of timely referrals 
to designated hospitals. Moreover, STEMI patients highly 
suspicious of COVID-19 should be isolated and screened via 
laboratory and imaging tests, and the medical staff should 
use full personal protective equipment (PPE).
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Fig. 1  Trend of primary percu-
taneous coronary intervention 
in general and heart hospitals 
in the fall and winter of the last 
2 years
